CurrentEndo coverage · page 9 of 33

Cardiovascular Diabetology

Briefs 321–360 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol8 Oct 2025
Deep learning-based coronary calcium score derived from non-gated chest CT and major adverse cardiovascular events in patients with type 2 diabetes mellitus
Cohort studyT2D & other
Cardiovasc Diabetol8 Oct 2025
Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus
Case-control studyT2D & other
Cardiovasc Diabetol8 Oct 2025
Association of epicardial fat volume index with coronary artery disease phenotypes based on anatomical and functional imaging: a linkage with the severity of coronary artery disease
Cohort study
Cardiovasc Diabetol6 Oct 2025
Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS
Cohort study
Cardiovasc Diabetol6 Oct 2025
Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes
Cohort studyT2D & other
Cardiovasc Diabetol3 Oct 2025
Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial
Secondary analysisLipids & liver
Cardiovasc Diabetol3 Oct 2025
Development and evaluation of a machine learning prediction model for short-term mortality in patients with diabetes or hyperglycemia at emergency department admission
Cohort studyT2D & other
Cardiovasc Diabetol2 Oct 2025
Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study
Cohort studyObesity
Cardiovasc Diabetol1 Oct 2025
Triglyceride glucose index in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study
Cohort study
Cardiovasc Diabetol1 Oct 2025
Association between metabolic score for insulin resistance and future stroke risk in patients with cardiovascular-kidney-metabolic syndrome stages 0–3: a longitudinal analysis based on CHARLS
Cohort study
Cardiovasc Diabetol1 Oct 2025
Testosterone therapy is associated with reduced risk of acute kidney injury, kidney failure with renal replacement therapy, and cardiovascular events in men with diabetes and hypogonadism
Cohort studyReproductive endocrine
Cardiovasc Diabetol30 Sep 2025
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study
Cross-sectional studyComplications
Cardiovasc Diabetol30 Sep 2025
An ensemble machine learning-based risk stratification tool for 30-day mortality prediction in critically ill cardiovascular patients
Cohort studyT2D & other
Cardiovasc Diabetol30 Sep 2025
Associations of six insulin resistance-related indices with the risk and progression of cardio-renal-metabolic multimorbidity: evidence from the UK biobank
Cohort study
Cardiovasc Diabetol30 Sep 2025
Effect of changes in the triglyceride-glucose index on atherogenic lipid profiles in coronary artery disease patients receiving lipid-lowering therapy: a prospective cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol30 Sep 2025
Planetary health diet, other plant-based diets and risk of type 2 diabetes: a prospective study from the UK Biobank
Cohort studyT2D & other
Cardiovasc Diabetol30 Sep 2025
Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial
Cohort studyT2D & other
Cardiovasc Diabetol30 Sep 2025
Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis
Meta-analysisT2D & other
Cardiovasc Diabetol30 Sep 2025
Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort
Cohort studyLipids & liver
Cardiovasc Diabetol29 Sep 2025
Accelerated biological aging mediates the associations of stress hyperglycemia ratio (SHR) with mortality in type 2 diabetes and obesity (diabesity)
Cohort studyT2D & other
Cardiovasc Diabetol29 Sep 2025
Association of the triglyceride-glucose index and its combination with obesity indices with cardio-renal-metabolic multimorbidity: two decades of follow-up in the Tehran Lipid and Glucose Study
Cohort studyT2D & other
Cardiovasc Diabetol24 Sep 2025
The association between triglyceride-glucose index and all-cause/cardiovascular mortality in patients with different glucose metabolism statuses
Cohort studyT2D & other
Cardiovasc Diabetol23 Sep 2025
Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: findings from two prospective cohorts
Cohort study
Cardiovasc Diabetol23 Sep 2025
Treatment and associated outcomes of type 2 diabetes mellitus patients with a cardiovascular comorbidity and comparison with guideline recommendations: a German claims data analysis
Cohort studyT2D & other
Cardiovasc Diabetol23 Sep 2025
Fixed-dose vs loose-dose combination antidiabetic therapy and cardiorenal outcomes in type 2 diabetes: a nationwide comparative effectiveness study
Cohort studyT2D & other
Cardiovasc Diabetol11 Sep 2025
Insulin resistance assessed by estimated glucose disposal rate predicts cardiovascular disease in stages 0–3 of cardiovascular-kidney-metabolic syndrome: a UK biobank cohort study
Cohort study
Cardiovasc Diabetol8 Sep 2025
Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial
Secondary analysisT2D & other
Cardiovasc Diabetol2 Sep 2025
The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study
Cohort study
Cardiovasc Diabetol1 Sep 2025
Association between dynamic changes in the triglyceride-glucose index and prognosis in patients with acute ST-segment elevation myocardial infarction
Cohort study
Cardiovasc Diabetol31 Aug 2025
Pericoronary adipose tissue radiomics to improve risk stratification for patients with acute coronary syndrome: a multicenter retrospective cohort study
Cohort study
Cardiovasc Diabetol31 Aug 2025
Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes
Secondary analysisT2D & other
Cardiovasc Diabetol31 Aug 2025
Nocturnal hypoxemic burden is associated with worsening prognosis of chronic kidney disease in patients with type 2 diabetes
Cohort studyComplications
Cardiovasc Diabetol31 Aug 2025
SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease
Cohort studyT2D & other
Cardiovasc Diabetol31 Aug 2025
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study
Randomized controlled trialT2D & other
Cardiovasc Diabetol31 Aug 2025
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease
Cross-sectional studyT2D & other
Cardiovasc Diabetol25 Aug 2025
Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-Year cohort study
Cohort studyT2D & other
Cardiovasc Diabetol25 Aug 2025
Associations between steatotic liver disease subtypes and incident atrial fibrillation in young adults: a nationwide cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol23 Aug 2025
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Secondary analysisT2D & other
Cardiovasc Diabetol22 Aug 2025
Lipid metabolism-related inflammatory indices (LMIIs) and incident peripheral artery diseases (PAD) in patients with type 2 diabetes mellitus (T2DM): a multicohort study from China and the UK biobank
Research articleT2D & other
Cardiovasc Diabetol21 Aug 2025
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis
Meta-analysisT2D & other

All 1,291 Briefs in ExploreShowing Briefs 321–360 of 1,291, newest first